Innovation of Lipid‐Based Nanoparticles: the Design and Applications in the Cardiovascular Disease Management
- 9 October 2024
- journal article
- review article
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (2)
Abstract
Cardiovascular diseases (CVDs) represent a prominent cause of global mortality, posing considerable challenges for traditional therapies due to their limited bioavailability and notable side effects. Similarly, imaging diagnostic modalities have inherent limitations. Lipid‐based nanoparticles (LNPs) have emerged as promising tools for precise diagnosis and treatment of CVDs, owing to their exceptional biocompatibility, modifiability, and compatibility with payloads, showcasing extensive potential for diverse applications. LNPs excel in encapsulating diverse drug compounds, protecting against drug degradation, and enabling targeted drug delivery at lesion sites. Moreover, in conjunction with multimodal imaging techniques, LNPs enhance the accuracy of diagnosing and treating CVDs. Nevertheless, this field lacks comprehensive and up‐to‐date reviews. Therefore, this review delineates the foundational principles governing nano‐strategies employing LNP systems for addressing CVDs. It explores recent advancements in utilizing these strategies for diagnosing and treating different cardiovascular conditions while also pointing out their limitations. This review aims to provide insights for future research endeavors.Keywords
Funding Information
- National Natural Science Foundation of China (82372148, 82172168, 82372202)
- National Key Research and Development Program of China (2021YFF0703500, 2022YFE0103500)
This publication has 131 references indexed in Scilit:
- A perspective of lipid nanoparticles for RNA deliveryExploration, 2024
- Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying lengthJournal of Biomedical Materials Research Part A, 2024
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- PEGylated therapeutics in the clinicBioengineering & Translational Medicine, 2023
- Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional ExtensionsAdvanced Science, 2023
- A ROS‐Responsive Liposomal Composite Hydrogel Integrating Improved Mitochondrial Function and Pro‐Angiogenesis for Efficient Treatment of Myocardial InfarctionAdvanced Healthcare Materials, 2022
- Lipid Nanoparticles for Drug DeliveryAdvanced NanoBiomed Research, 2021
- Platelet‐Like Fusogenic Liposome‐Mediated Targeting Delivery of miR‐21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia‐Reperfusion InjuryAdvanced Science, 2021
- Liposomal Nanotherapy for Treatment of AtherosclerosisAdvanced Healthcare Materials, 2020
- Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial InfarctionJAMA, 2016